Many postmenopausal women are prescribed antiresorptive agents to prevent or treat osteoporosis.  Patients receiving these antiresorptive agents incuding bisphosphonates, Fosamax, Boniva, Prolia, and cathespin K inhibitors have a 0.10% risk of developing osteoradionecrosis of the jaw (ARONJ).   Before having tooth extractions patients need to inform their dentist that they are taking these antiresorptive agents so preventative measures can be taken.  Routine dental care does not increase the risk of ARONJ.  The benefit of taking these antiresorptive agents far outweighs the small risk of developing ARONJ.